Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02648490
Title An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Henlix, Inc
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Henlix, Inc. Fremont California 94538 United States Details
Linkou Chang Gung Memorial Hospital Taoyuan Taiwan Details
*Shaded cells indicate that there was no data available from for the field